Trial Identifier: | D081LR00002 |
Sponsor: | AstraZeneca |
NCTID:: | NCT04425200 |
Start Date: | July 2020 |
Primary Completion Date: | December 2020 |
Study Completion Date: | December 2020 |
Condition: | Prostate Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Japan, Aichi | Nagoya, Aichi, Japan |
Japan, Aomori | Hirosaki, Aomori, Japan |
Japan, Chiba | Chiba, Japan |
Japan, Chiba | Kashiwa, Chiba, Japan |
Japan, Ehime | Toon, Ehime, Japan |
Japan, Gifu | Gifu, Japan |
Japan, Hiroshima | Kure, Hiroshima, Japan |
Japan, Hokkaido | Hakodate, Hokkaido, Japan |
Japan, Hokkaido | Sapporo, Hokkaido, Japan |
Japan, Hyogo | Kobe, Hyogo, Japan |
Japan, Ibaraki | Tsukuba, Ibaraki, Japan |
Japan, Ishikawa | Kanazawa, Ishikawa, Japan |
Japan, Kagawa | Miki, Kagawa, Japan |
Japan, Kanagawa | Yokohama, Kanagawa, Japan |
Japan, Kyoto | Kyoto, Japan |
Japan, Miyazaki | Miyazaki, Japan |
Japan, Nara | Kashihara, Nara, Japan |
Japan, Okayama | Okayama, Japan |
Japan, Osaka | Osakasayama, Osaka, Japan |
Japan, Saitama | Kawagoe, Saitama, Japan |
Japan, Tottori | Yonago, Tottori, Japan |
Japan, Yamaguchi | Ube, Yamaguchi, Japan |